Cargando…
Anti-Diabetic Effect of Telmisartan Through its Partial PPARγ-Agonistic Activity
Telmisartan is an angiotensin II receptor antagonist, which selectively inhibits the angiotensin II type 1 receptor. Thus, it is widely used for hypertension management. Nowadays, telmisartan’s effect on peroxisome proliferator-activated receptors (PPARs) is gaining wider attention. PPARs are ligand...
Autores principales: | Ayza, Muluken Altaye, Zewdie, Kaleab Alemayehu, Tesfaye, Bekalu Amare, Gebrekirstos, Selamawit Tesfamariam, Berhe, Derbew Fikadu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567533/ https://www.ncbi.nlm.nih.gov/pubmed/33116714 http://dx.doi.org/10.2147/DMSO.S265399 |
Ejemplares similares
-
A Systematic Review on Rho-Kinase as a Potential Therapeutic Target for the Treatment of Erectile Dysfunction
por: Zewdie, Kaleab Alemayehu, et al.
Publicado: (2020) -
Montelukast: The New Therapeutic Option for the Treatment of Epilepsy
por: Tesfaye, Bekalu Amare, et al.
Publicado: (2021) -
The Role of Antioxidants in Ameliorating Cyclophosphamide-Induced Cardiotoxicity
por: Ayza, Muluken Altaye, et al.
Publicado: (2020) -
Targeting Netrin-1 and -4 as a Novel Diagnostic Parameter and Treatment Option for Diabetic Retinopathy
por: Zewdie, Kaleab Alemayehu, et al.
Publicado: (2020) -
Antileishmanial Activity of Tamoxifen by Targeting Sphingolipid Metabolism: A Review
por: Zewdie, Kaleab Alemayehu, et al.
Publicado: (2022)